BioSpace News Archive

BioCapital

OpGen to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022

OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced it is participating in Edison Group’s Open House Event, scheduled to take place virtually this month.

January 18, 2022
·
2 min read
Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation

Bausch Health Companies Inc. announced that it is seeking to refinance its existing credit agreement.

January 18, 2022
·
8 min read
Business

Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access

Apollo Endosurgery, Inc. today announced the hiring of Keely Scamperle as Vice President, Reimbursement & Market Access, effective January 17, 2022.

January 18, 2022
·
4 min read
Business

Ilumed Announces Appointment of David J. Priscal, M.D., As Chief Medical Officer

Ilumed, a Medicare transformation company focused on assisting patients to achieve their healthiest lives by driving lower-cost, better-quality and more-equitable healthcare outcomes, today announced the appointment of David J. Priscal, M.D., as Chief Medical Officer.

January 18, 2022
·
3 min read
Business

VBL Therapeutics Announces Appointment of Matthew Trudeau as Chief Commercial Officer

VBL Therapeutics today announced the appointment of Matthew Trudeau to the newly created position of Chief Commercial Officer (CCO).

January 18, 2022
·
5 min read
BioForest

Impel NeuroPharma Provides Updates on Trudhesa™ Launch and Recent Business Highlights

Impel NeuroPharma today provided updates on Trudhesa™ (dihydroergotamine mesylate) nasal spray (0.725 mg per spray) launch progress and recent business highlights.

January 18, 2022
·
11 min read
Business

Kymera Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to Board of Directors

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of John Maraganore, Ph.D. to its Board of Directors.

January 18, 2022
·
4 min read
Paradigm4 Joins the Tetra Partner Network to Leverage Tetra Data into High-performing Analytical Computing Applications for Pharmaceutical Customers

Partnership Signals Continued Recognition of Tetra Data as a Universally Adoptable Scientific Data Standard.

January 18, 2022
·
3 min read
Drug Development

SciSparc Advances Its Phase IIb Clinical Trial in Patients with Tourette Syndrome with its Proprietary Drug Candidate SCI-110

SciSparc Ltd. (NASDAQ: SPRC), today announced that it has entered into an agreement with two clinical sites: Hannover Medical School in Hannover, Germany, and Tel-Aviv Sourasky Medical School, in Tel-Aviv, Israel, to further its Phase IIb clinical study for SCI-110.

January 18, 2022
·
6 min read
Pharm Country

PTC Therapeutics Announces Launch of 8th Annual STRIVE™ Awards Program to Fund Initiatives Benefitting the Duchenne Muscular Dystrophy Community

PTC Therapeutics, Inc. announced the launch of the eighth annual STRIVE™ awards program for Duchenne muscular dystrophy.

January 18, 2022
·
4 min read